iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Arrow Greentech-led Avery Pharma starts production at Sanand unit; Stock jumps 12%

12 Sep 2022 , 03:53 PM

Arrow Greentech Limited’s Wholly Owned Subsidiary (WOS) Company Avery Pharmaceuticals Private Limited has started the commercial production of pharmaceutical & nutraceutical products in its manufacturing unit situated at Sanand, Ahmedabad on August 17, 2022.
As per the regulatory filing, this plant is dedicated for Mouth dissolving strip (MOS) manufacturing and Avery is a MOS manufacturing company to have signed an MOU at Vibrant Gujarat and has been appreciated by the Gujarat Government to launch Novel technology and raise standards of Drug delivery system.
Avery Pharma is approved with WHO-GMP followed by approvals of FDCA, FSSAI and ISO, GMP, GLP. The plant is approved to manufacture the Pharmaceuticals and Nutraceuticals range of products. The R&D of the plant is dedicated and fully equipped to undertake developments of novel technology including Sublingual films, buccal films, transdermal patches, veterinary films, combination films, Nanofilms, etc. 
The Plant houses a facility for in-house testing of the products. There is a separate provision for QC chemical and Micro testing of products and the production method follows semi-automatic and automatic processes, with high precision sensors for manufacture of quality products and entails minimal human intervention.

On Monday early morning trade, Arrow Greentech was trading at Rs91.50 per share higher by 12.68% on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Arrow Greentech Limited
  • Arrow Greentech Limited shares
  • Arrow Greentech Limited stocks
  • Avery Pharmaceuticals
  • business update
  • market
  • news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.